These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 2743716)

  • 1. Treatment of Behçet's disease with dapsone.
    Hamza M; Hamzaoui K; Ayed K
    Clin Rheumatol; 1989 Mar; 8(1):113-4. PubMed ID: 2743716
    [No Abstract]   [Full Text] [Related]  

  • 2. Suppression of Behçet's disease with dapsone.
    Sharquie KE
    Br J Dermatol; 1984 Apr; 110(4):493-4. PubMed ID: 6712889
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Effectiveness of dapsone in Behcet's disease.
    Convit J; Goihman-Yahr M; Rondón-Lugo AJ
    Br J Dermatol; 1984 Nov; 111(5):629-30. PubMed ID: 6498097
    [No Abstract]   [Full Text] [Related]  

  • 4. [Behcet's syndrome].
    Kursanov IuV; Sheĭnkman EV
    Klin Med (Mosk); 1973 Oct; 51(10):130-3. PubMed ID: 4787272
    [No Abstract]   [Full Text] [Related]  

  • 5. Behcet's syndrome presenting as FUO.
    Fatima J; Shukla V; Karoli R
    J Assoc Physicians India; 2010 May; 58():331-2. PubMed ID: 21121102
    [No Abstract]   [Full Text] [Related]  

  • 6. Dapsone in Behçet's disease: a double-blind, placebo-controlled, cross-over study.
    Sharquie KE; Najim RA; Abu-Raghif AR
    J Dermatol; 2002 May; 29(5):267-79. PubMed ID: 12081158
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Behçet's disease. Report of twenty-five patients from the United States with prominent mucocutaneous involvement.
    Mangelsdorf HC; White WL; Jorizzo JL
    J Am Acad Dermatol; 1996 May; 34(5 Pt 1):745-50. PubMed ID: 8632067
    [TBL] [Abstract][Full Text] [Related]  

  • 8. N-acetyltransferase polymorphism in patients with Behçet's disease.
    Aynacioglu AS; Bozkurt A; Nacak M; Kortunay S; Tunc R; Dincel A; Kayaalp SO
    Eur J Clin Pharmacol; 2001 Nov; 57(9):659-62. PubMed ID: 11791896
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Behcet's disease therapy review].
    Vidaller Palacín A; Robert Olalla J; Sanuy Jiménez B; Rufi Rigau G; Folch Civit J; Charte González A
    An Med Interna; 2002 Nov; 19(11):594-8. PubMed ID: 12522899
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Behçet's syndrome with pyoderma-gangrenosum-like lesions treated successfully with dapsone monotherapy.
    Joshi A; Mamta
    J Dermatol; 2004 Oct; 31(10):806-10. PubMed ID: 15672708
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Behçet's disease and complex aphthosis.
    Ghate JV; Jorizzo JL
    J Am Acad Dermatol; 1999 Jan; 40(1):1-18; quiz 19-20. PubMed ID: 9922007
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Mucocutaneous Involvement in Behçet's Disease: How Systemic Treatment Has Changed in the Last Decades and Future Perspectives.
    Rotondo C; Lopalco G; Iannone F; Vitale A; Talarico R; Galeazzi M; Lapadula G; Cantarini L
    Mediators Inflamm; 2015; 2015():451675. PubMed ID: 26185360
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Colchicine in the treatment of the cutaneous manifestations of Behçet's disease.
    Miyachi Y; Taniguchi S; Ozaki M; Horio T
    Br J Dermatol; 1981 Jan; 104(1):67-9. PubMed ID: 7459271
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behçet's disease. New perspectives on an enigmatic syndrome.
    Arbesfeld SJ; Kurban AK
    J Am Acad Dermatol; 1988 Nov; 19(5 Pt 1):767-79. PubMed ID: 3056991
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Acetylator phenotype in Behçet's disease.
    Najim RA; Sharquie KE; Al-Janabi MH
    Adv Exp Med Biol; 2003; 528():131-8. PubMed ID: 12918677
    [No Abstract]   [Full Text] [Related]  

  • 16. [Preliminary study of the therapeutic effect of superoxide dismutase in 7 cases of Behçet's disease].
    Emerit J; Jeny C; Emerit I; Le Hoang P; Caen OL; Pelletier S; Mollet M; Congy F
    C R Acad Sci III; 1986; 302(7):243-6. PubMed ID: 3084046
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Investigation of ABCB1 gene polymorphism with colchicine response in Behçet's disease.
    Saricaoglu H; Yilmaz M; Karkucak M; Ozturk HZ; Yakut T; Gulten T; Baskan EB; Aydogan K; Dilek K
    Genet Mol Res; 2011 Jan; 10(1):1-6. PubMed ID: 21218380
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Intracranial hemorrhage in neuro-Behçet's syndrome.
    Kikuchi S; Niino M; Shinpo K; Terae S; Tashiro K
    Intern Med; 2002 Sep; 41(9):692-5. PubMed ID: 12322793
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Behçet's disease. Attempt at treatment with thalidomide].
    Bennouna-Biaz F; Benharbit R; Heid E; Senouci-Belkhadir K; Lazrak B
    Maghrib Tibbi; 1986 Jun; 8(2):301-8. PubMed ID: 3613658
    [No Abstract]   [Full Text] [Related]  

  • 20. Cyclosporin in Behçet's disease.
    Lancet; 1983 Aug; 2(8347):454-5. PubMed ID: 6135934
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.